Puma Biotechnology Investor Relations Material
Latest events
Q2 2025
Puma Biotechnology
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Puma Biotechnology Inc
Access all reports
Puma Biotechnology Inc. is a biopharmaceutical company focused on the development and commercialization of therapies for the treatment of cancer. The company specializes in targeted oncology, developing drugs that aim to improve outcomes for patients with specific types of cancer by addressing unmet medical needs. It collaborates with healthcare professionals, researchers, and regulatory bodies to advance its clinical and commercial objectives. The company is headquartered in Los Angeles, California, and its shares are listed on the NASDAQ.
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
PBYI
Country
🇺🇸 United States